Complementary Use of US FDA's Adverse Event Reporting System and Sentinel Distributed Database to Characterize Direct Oral Anticoagulants Associated Cutaneous Small Vessel Vasculitis

    Basic Details
    Date
    Tuesday, August 27, 2019
    Type
    Presentation
    Medical Product
    direct oral anticoagulant (DOAC)
    Health Outcome(s)
    cutaneous small-vessel vasculitis
    Presenter(s)

    Mohamed Mohamoud, Casie Horgan, Veronica Sansing-Foster, Elizabeth Dee, Justin Bohn, Oren Shapira, Efe Eworuke, Monica Munoz, Danijela Stojanovic, Lois La Grenade